Autoantigenes for improved diagnosis, prognosis and treatment of inflammatory neurological diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 19, 2013
Grant Date -
Oct 8, 2009
app pub date -
Apr 8, 2009
filing date -
Oct 11, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
According to the invention, autoantibodies, the appearance of which is characteristic of neurological autoimmune diseases, especially multiple sclerosis, are detected and the respective autoantigens identified. It can further be shown that many of these autoantigens are expressed specifically in the brain. The identification of the autoantigens and autoantibodies is useful for diagnosis and treatment. A brain-specific expression of the autoantigens further emphasizes an important role of the antigens and antibodies in the origin and development of neurological autoimmune diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully